20.11.2014 Views

Guidance on registration - ECHA - Europa

Guidance on registration - ECHA - Europa

Guidance on registration - ECHA - Europa

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

66<br />

<str<strong>on</strong>g>Guidance</str<strong>on</strong>g> <strong>on</strong> registrati<strong>on</strong><br />

Versi<strong>on</strong> 2.0 May 2012<br />

substance in a quantity over <strong>on</strong>e t<strong>on</strong>ne per year for the first time after 1 December 2008. To<br />

benefit from this, the producer or importer will have to submit a pre-registrati<strong>on</strong> dossier within<br />

six m<strong>on</strong>ths of first using the substance for the producti<strong>on</strong> of the articles or first importing the<br />

article c<strong>on</strong>taining the substance and no later than 12 m<strong>on</strong>ths before the registrati<strong>on</strong> deadline<br />

for their t<strong>on</strong>nage band.<br />

Note that in the case of a n<strong>on</strong>-EU manufacturer appointing an <strong>on</strong>ly representative, it will be<br />

the <strong>on</strong>ly representative who will have to pre-register the substance in order to benefit from the<br />

extended registrati<strong>on</strong> deadlines. An <strong>on</strong>ly representative appointed after 1 December 2008 can<br />

pre-register the substance until 12 m<strong>on</strong>ths before the relevant registrati<strong>on</strong> deadline, provided<br />

that the substance originating from the n<strong>on</strong>-EU manufacturer was not placed <strong>on</strong> the market<br />

previously in a quantity at or above <strong>on</strong>e t<strong>on</strong>ne per year after 1 June 2008 (when the<br />

registrati<strong>on</strong> obligati<strong>on</strong>s entered into force). If a n<strong>on</strong>-EU manufacturer decides to change his<br />

<strong>on</strong>ly representative and the previous <strong>on</strong>ly representative had pre-registered the substance<br />

originating from the n<strong>on</strong>-EU manufacturer, then the successor should communicate the change<br />

of <strong>on</strong>ly representative to <strong>ECHA</strong> in order to c<strong>on</strong>tinue to benefit from the phase-in deadlines for<br />

registrati<strong>on</strong> of that substance.<br />

Legal reference: Article 28<br />

4.3 SIEF formati<strong>on</strong><br />

All potential registrants and data holders for the same pre-registered phase-in substance are<br />

participants in a ‘Substance Informati<strong>on</strong> Exchange Forum’ (SIEF). Registrants who registered<br />

the same phase-in substance earlier, or whose substance is c<strong>on</strong>sidered as registered (see<br />

secti<strong>on</strong> 2.2.4) are also participants of the SIEF.<br />

The aims of the SIEF are to:<br />

<br />

<br />

facilitate data sharing for the purposes of registrati<strong>on</strong>, thereby avoiding the duplicati<strong>on</strong><br />

of studies, and<br />

agree <strong>on</strong> the classificati<strong>on</strong> and labelling of the substance c<strong>on</strong>cerned where there is a<br />

difference in the classificati<strong>on</strong> and labelling of the substance between the potential<br />

registrants.<br />

Participants are free to organise themselves as they see fit to carry out their duties and<br />

obligati<strong>on</strong>s under REACH, The organisati<strong>on</strong> used for the SIEF co-operati<strong>on</strong> may also be used to<br />

jointly submit the relevant informati<strong>on</strong>.<br />

Note that the resp<strong>on</strong>sibility for defining the ‘sameness’ of the substances lies with the SIEF<br />

participants.<br />

The <str<strong>on</strong>g>Guidance</str<strong>on</strong>g> <strong>on</strong> data sharing provides extensive informati<strong>on</strong> <strong>on</strong> the rights and duties of SIEF<br />

participants. The reader is advised to c<strong>on</strong>sult this guidance if in need of further informati<strong>on</strong> <strong>on</strong><br />

the subject.<br />

Legal reference: Article 29<br />

4.4 Inquiry for n<strong>on</strong> phase-in and n<strong>on</strong> pre-registered phase-in<br />

substances<br />

Inquiry is the process by which every potential registrant must inquire from <strong>ECHA</strong> whether a<br />

registrati<strong>on</strong> has already been submitted for the same substance. This is to ensure that data<br />

are shared by the relevant parties. The duty to inquire applies to n<strong>on</strong> phase-in substances and<br />

to phase-in substances that have not been pre-registered.<br />

Therefore, for n<strong>on</strong> phase-in substances and for phase-in substances that have not<br />

Annankatu 18, P.O. Box 400, FI-00121 Helsinki, Finland | Tel. +358 9 686180 | Fax +358 9 68618210 | echa.europa.eu

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!